Table 1.
Participants baseline characteristics (n = 30).
| n | % | ||
|---|---|---|---|
| Disease Stage | |||
| 0 | 6 | 20 | |
| I | 15 | 50 | |
| II | 9 | 30 | |
| III | - | - | |
| Menopausal Status | |||
| Postmenopausal | 18 | 64.3 | |
| Surgery Type | |||
| Mastectomy | 3 | 10.0 | |
| Quadrantectomy | 26 | 87.7 | |
| Lumpectomy | 1 | 3.3 | |
| Treatment in Addition to Surgery | |||
| Only radiation | 2 | 6.7 | |
| Only chemotherapy | 13 | 43.3 | |
| Radiation and chemotherapy | 4 | 13.3 | |
| None | 11 | 36.7 | |
| Current Endocrine Therapy | |||
| None | 6 | 20.0 | |
| Tamoxifen | 8 | 26.7 | |
| Aromatase inhibitor | 16 | 53.3 | |
Abbreviations: n, number of participants; %, percentage of total number of participants.